Total flower extracts of Hypericum perforatum L. obtained with 3 different solvent systems were tested on tumour cell line cultures by comparing two groups of plants harvested in different times and places. The extracts, characterized according to the spectroscopic profile and the hypericin content, were tested on the growth and apoptotic death of K562 cells, a human erythroleukemic cell line. Growth and apoptosis were analysed by viable cell count, flow cytometry, and fluorescence microscopy at 6, 24, and 48 hr of culture following 1 hr exposure to the extracts under investigation. Here, we show that Hypericum extracts are able to reduce the growth of K562 cells and induce different degrees and kinetics of apoptosis according to the group of plants of origin. Also, we highlighted interesting differences in terms of efficacy among the extracts, with some samples losing their effectiveness along the culture time and others able to maintain or even increase their efficacy. Furthermore, the data herein obtained confirm the role of non hypericin compounds that are present in different proportions in the two plant groups and in the extracts analysed.

Valletta, E., Rinaldi, A., Marini, M., Franzese, O., Roscetti, G. (2018). Distinct Hypericum perforatum L. total extracts exert different antitumour activity on erythroleukemic K562 cells. PHYTOTHERAPY RESEARCH, 32(9), 1803-1811 [10.1002/ptr.6114].

Distinct Hypericum perforatum L. total extracts exert different antitumour activity on erythroleukemic K562 cells

Valletta E.;Rinaldi A.;Marini M.;Franzese O.;Roscetti G.
2018-01-01

Abstract

Total flower extracts of Hypericum perforatum L. obtained with 3 different solvent systems were tested on tumour cell line cultures by comparing two groups of plants harvested in different times and places. The extracts, characterized according to the spectroscopic profile and the hypericin content, were tested on the growth and apoptotic death of K562 cells, a human erythroleukemic cell line. Growth and apoptosis were analysed by viable cell count, flow cytometry, and fluorescence microscopy at 6, 24, and 48 hr of culture following 1 hr exposure to the extracts under investigation. Here, we show that Hypericum extracts are able to reduce the growth of K562 cells and induce different degrees and kinetics of apoptosis according to the group of plants of origin. Also, we highlighted interesting differences in terms of efficacy among the extracts, with some samples losing their effectiveness along the culture time and others able to maintain or even increase their efficacy. Furthermore, the data herein obtained confirm the role of non hypericin compounds that are present in different proportions in the two plant groups and in the extracts analysed.
2018
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore BIO/09 - FISIOLOGIA
Settore BIO/14 - FARMACOLOGIA
English
Hypericum compounds; apoptosis; cancer; cell growth; total extracts; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Flowers; Humans; Hypericum; K562 Cells; Perylene; Plant Extracts; Solvents
Valletta, E., Rinaldi, A., Marini, M., Franzese, O., Roscetti, G. (2018). Distinct Hypericum perforatum L. total extracts exert different antitumour activity on erythroleukemic K562 cells. PHYTOTHERAPY RESEARCH, 32(9), 1803-1811 [10.1002/ptr.6114].
Valletta, E; Rinaldi, A; Marini, M; Franzese, O; Roscetti, G
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/217866
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 11
  • ???jsp.display-item.citation.isi??? 9
social impact